000 | 01621nam a2200193Ia 4500 | ||
---|---|---|---|
008 | 140223b2008 xxu||||| |||| 00| 0 eng d | ||
020 |
_a9780470107508 _c0.00 |
||
082 |
_a615.191 _bLED |
||
100 |
_aLednicer, Daniel _916165 |
||
245 | _aThe Organic Chemistry of Drug Synthesis. Vol. 7 | ||
260 |
_aNew Jersey _bJohn Wiley & Sons Inc. _c2008 |
||
300 | _a272p | ||
500 | _aThe seventh volume in the definitive series that provides a quick yet thorough overview of the synthetic routes used to access specific classesof therapeutic agents, this volume covers approximately 220 new non-proprietary drug entities introduced since the publication of Volume 6.Many of these compounds represent novel structural types firstidentified by sophisticated new cell-based assays. Specifically, a significant number of new antineoplastic and antiviral agents are covered.As in the previous volumes, materials are organized by chemical class and syntheses originate with available starting materials. Organized to make the information accessible, this resource covers disease state, rationale for method of drug therapy, and the biological activities of each compound and preparation. The Organic Chemistry of Drug Synthesis, Volume 7 is a hands-on reference for medicinal and organic chemists, and a great resource for graduate and advanced undergraduate students in organic and medicinal chemistry. | ||
600 |
_aDrug _916166 |
||
600 |
_aOrganic Chemistry _94188 |
||
600 |
_aPharmaceutical Chemistry _9370 |
||
942 |
_2ddc _cLB _k615.191 _mLED |
||
995 |
_aPharmacy Reference _eP0004904 _j615.191 _yP0004904 |
||
999 |
_c15948 _d15948 |